Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · IEX Real-Time Price · USD
9.20
+0.08 (0.88%)
At close: May 17, 2024, 4:00 PM
9.12
-0.08 (-0.87%)
After-hours: May 17, 2024, 7:57 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.07 billion as of May 17, 2024. Its market cap has increased by 61.15% in one year.
Market Cap
1.07B
Enterprise Value
874.23M
1-Year Change
61.15%
Ranking
Category
Stock Price
$9.20
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $764.40M to $1.07B, an increase of 40.24%. That is a compound annual growth rate of 8.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 1.07B | 0.87% |
May 16, 2024 | 1.06B | -1.30% |
May 15, 2024 | 1.07B | 13.65% |
May 14, 2024 | 941.20M | 21.68% |
May 13, 2024 | 773.50M | 1.91% |
May 10, 2024 | 759.00M | -2.24% |
May 9, 2024 | 776.40M | 0.37% |
May 8, 2024 | 773.50M | 1.39% |
May 7, 2024 | 762.90M | -0.88% |
May 6, 2024 | 769.70M | -0.62% |
May 3, 2024 | 774.50M | -6.98% |
May 2, 2024 | 832.60M | -2.71% |
May 1, 2024 | 855.80M | 6.24% |
Apr 30, 2024 | 805.50M | -5.24% |
Apr 29, 2024 | 850.00M | 3.66% |
Apr 26, 2024 | 820.00M | -1.39% |
Apr 25, 2024 | 831.60M | -1.83% |
Apr 24, 2024 | 847.10M | 0.12% |
Apr 23, 2024 | 846.10M | -2.24% |
Apr 22, 2024 | 865.50M | -1.76% |
Apr 19, 2024 | 881.00M | -3.71% |
Apr 18, 2024 | 914.90M | -7.80% |
Apr 17, 2024 | 992.30M | 1.48% |
Apr 16, 2024 | 977.80M | 0.10% |
Apr 15, 2024 | 976.80M | -1.08% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cronos Group | 1.11B |
AtriCure | 1.11B |
Cassava Sciences | 1.11B |
Pharvaris | 1.10B |
Enliven Therapeutics | 1.08B |
AbCellera Biologics | 1.07B |
Collegium Pharmaceutical | 1.06B |
Verona Pharma | 1.06B |